GoodRx Holdings, Inc.

GDRX · Technology · $1.1B mkt cap · FY2025 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat
Share / Embed this score
Embed this score

The five investor questions

63

2021–2025 (latest 5 aligned FYs; v3 window cap 5): revenue $745M to $797M, increasing; diluted EPS -0.06 to 0.09, increasing.

Not enough years of gross-margin data to score pricing power.

0

Median ROIC 1.1%, above the 12% hurdle in 0% of years.

37

Net debt/EBITDA 1.3x, interest coverage 2x.

78

Owner earnings changed +11.4%/yr over up to the ten most recent annual observations, share count n/a.

The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.

Price vs. value if growth stopped today

A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.

Above value if growth stopped todayBelow value if growth stopped today
12% above value if growth stopped today
$84.7M
$2.64
$2.64
$2.96
12% above value if growth stopped today

What today’s price assumes: owner earnings growing ~2%/yr over 5 years. The zero-growth estimate assumes owner earnings stay flat (0% growth).

How to read this

We solve for the constant annual change in owner earnings that would make the five-year zero-growth estimate equal today’s price. This keeps the existing model inputs and calculation unchanged; it is an expectations lens, not a forecast.

This zero-growth estimate assumes trailing owner earnings persist — unreliable for declining businesses. The recent FY revenue series does not trigger the three-consecutive-declines flag.

Among the current top-score group, the median current price is 239% above the zero-growth estimate across 48 of the current top 50 companies by Moat Score with both values.

Score records captured Jul 26, 2026.

Exactly which 50 companies?

FTNT, META, MEDP, IBEX, MSFT, GOOGL, LULU, ANF, IDXX, TXRH, FHI, QLYS, FFIV, ADBE, LLY, MANH, VEEV, GRMN, SSD, MNST, DOCS, MCO, CPRT, NTAP, LRCX, NVDA, CORT, SFM, MPTI, ULTA, SN, RMD, ROL, PAYC, IRMD, INTU, DECK, MORN, LGCY, DAL, GWW, ISRG, MPWR, CTAS, LOPE, MRK, CMG, FAST, BKNG, ORLY

Missing a usable price or zero-growth estimate: ANF, BKNG.

Model details under moat-index@3.0.0: zero-growth multiple 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.

9 years of fundamentals

The business, in plain English

Across the filed record, revenue grew from $250M (FY2018) to $797M (FY2025) — about 18.0% a year compounded over 7 years.

It earned 6.7% on invested capital in the latest filed year, FY2025. Across the full 6-year measurable filed record, median ROIC was 1.1%. Over the v3 recent window (6 measurable filed years), median ROIC was 1.1%. The Returns on Capital filter above scores it 0/100.

The balance sheet carried $488M of total debt in FY2025 against $112M of owner earnings — roughly 4.4 years of owner earnings to retire it all. Balance-Sheet Safety scores it 37/100.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2017–FY2025 · 9 fiscal years, normalized from GDRX’s SEC filings

Sales, as filed$797M FY2025
$0$500M2017202020232025
Revenue kept after cost of goods

Not disclosed in GDRX’s filings for these years — we don’t estimate it.

Standard ROIC or separately labeled Operating ROICROIC 6.7% FY2025

Not meaningful FY2019: invested capital is negative (cash exceeds debt + equity)

−50%−25%0%2017202020232025
Cash an owner could take out$112M FY2025
−$200M$02017202020232025

The explained ROIC gaps have filed inputs but no meaningful positive invested-capital denominator. Other gaps mean the item is not in the filings for that year. The series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Flagship explainer

How GoodRx Holdings, Inc. makes its money

GoodRx Holdings, Inc.'s filing does not supply enough comparable lines for a truthful flow chart — here's what is filed:

Table alternative
Filed lineValue% of revenueSource
$797M100%
$87.5M11%
Income before tax$56.5M7%
Income tax$26.1M3%
$30.4M4%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

What GoodRx Holdings, Inc. owns — and owes

GoodRx Holdings, Inc.'s filing tags don't support a full breakdown — here's what is filed:

Table alternative
Filed lineValue% of assetsSource
Total assets$1.4B100%
Cash and equivalents$262M19%
$488M35%
Stockholders’ equity$616M44%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

What drives GoodRx Holdings, Inc.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity5%Tax burden54%net income ÷ pretax incomeInterest burden65%pretax ÷ operating incomeOperating margin11%operating income ÷ revenueAsset turnover0.57×revenue ÷ average assetsEquity multiplier2.08×average assets ÷ average equityAs of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
$30.4MFY2025
Income before tax$56.5MFY2025
Operating income$87.5MFY2025
$797MFY2025
Ending assets$1.4BFY2025
Beginning assets$1.4BFY2024
$616MFY2025
$725MFY2024
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

Flagship explainer

Where GoodRx Holdings, Inc.'s cash went

GoodRx Holdings, Inc.’s filing does not supply enough provenance-matched cash-flow lines for a truthful flow chart — here’s what is filed:

Table alternative
Filed lineValue% of cash from operationsSource
Cash from operations$168M100%
Depreciation and amortization$85.2M51%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Curated 19-manager tier

Who reported holding GoodRx Holdings, Inc.

Delayed public 13F reports for 2026-Q2—not live positions, trades, or recommendations.

0 holding0 exited0 not holding0/19 resolved19 unavailable

Named manager positions and quarter-over-quarter changes
ManagerReported positionQuarter-over-quarterFiling accession
Abrams CapitalUnavailableComparison unavailableFiling unavailable
Akre CapitalUnavailableComparison unavailableFiling unavailable
Baupost GroupUnavailableComparison unavailableFiling unavailable
Berkshire HathawayUnavailableComparison unavailableFiling unavailable
Brave Warrior AdvisorsUnavailableComparison unavailableFiling unavailable
Dodge & CoxUnavailableComparison unavailableFiling unavailable
First EagleUnavailableComparison unavailableFiling unavailable
FundsmithUnavailableComparison unavailableFiling unavailable
Gardner Russo & QuinnUnavailableComparison unavailableFiling unavailable
Gates Foundation TrustUnavailableComparison unavailableFiling unavailable
Mairs & PowerUnavailableComparison unavailableFiling unavailable
Markel / Markel-GaynerUnavailableComparison unavailableFiling unavailable
Oakmark / Harris AssociatesUnavailableComparison unavailableFiling unavailable
Pershing SquareUnavailableComparison unavailableFiling unavailable
Polen CapitalUnavailableComparison unavailableFiling unavailable
Sequoia / Ruane CunniffUnavailableComparison unavailableFiling unavailable
Southeastern Asset ManagementUnavailableComparison unavailableFiling unavailable
Tweedy, BrowneUnavailableComparison unavailableFiling unavailable
Yacktman Asset ManagementUnavailableComparison unavailableFiling unavailable

Position size uses shares and filed value from each manager’s 13F. Portfolio weight uses the eligible long-share filing denominator. Changes compare only with the immediately preceding calendar quarter.

Source: Filing source unavailable · event Jun 30, 2026 · retrieved Jul 26, 2026

Flagship explainer

What GoodRx Holdings, Inc. insiders reported

Records still being gathered — partial as of retrieval Aug 19, 2026.

Partial coverage: the incomplete Form 4 walk cannot establish no activity, an activity date, or zero counts.

Moat Score history

16 logged readings since Jul 17, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale44.6 / 100
0406080100WideNarrowShallowNo moatJul 20, 2026Jul 26, 2026

Breaks in the line mark methodology or normalizer upgrades — readings across versions aren’t compared, so a level shift there isn’t a change in the business.

Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars

  1. Normalizer upgraded unstamped (version unknown)tomoat-xbrl-normalizer@1.1.0 — readings across versions aren’t comparedJul 26, 2026
  2. Methodology upgraded moat-index@2.0.0tomoat-index@3.0.0 — readings across versions aren’t comparedJul 23, 2026
  3. Methodology upgraded moat-index@1.2.0tomoat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026

Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.

Insider activity

Form 4 reports mix P/S market or private transactions with compensation-plan mechanics. Activity casually described as “insider selling” can include compensation mechanics; awards, tax withholding, and option exercises are shown by their exact filed class here, never collapsed into “Bought” or “Sold.”

These are disclosed filing facts and arithmetic aggregates, not a signal or verdict.

This machine-readable surface covers SEC ownership filings from 2003; it does not represent earlier paper-era records.

Records still being gathered — partial as of retrieval Aug 19, 2026.

Among the rows shown, A/F/M acquisition, payment or withholding, and exercise or conversion rows outnumber S sale rows (25 versus 0). The filing codes alone do not establish that every such row arose from a compensation plan.

Trailing-12-month totals and the 90-day cluster result are withheld because this issuer walk is incomplete.

InsiderShares owned afterDateFiling detail
Chan Thomas (TC)Chief Accounting OfficerExercise or conversion of derivative security (M)Table I · Acquired · Class A Common Stock · 4 paired events10,115Not disclosedNot disclosedSee lot detailAug 15, 2026
4 filed lots
  • Table I · Class A Common Stock: 1,252 shares at Not disclosed · code M · owned after 9,832 · Paired event: 1,252 Restricted Stock Unit → 1,252 Class A Common Stock ·
  • Table I · Class A Common Stock: 1,686 shares at Not disclosed · code M · owned after 10,880 · Paired event: 1,686 Restricted Stock Unit → 1,686 Class A Common Stock ·
  • Table I · Class A Common Stock: 2,636 shares at Not disclosed · code M · owned after 12,658 · Paired event: 2,636 Restricted Stock Unit → 2,636 Class A Common Stock ·
  • Table I · Class A Common Stock: 4,541 shares at Not disclosed · code M · owned after 15,857 · Paired event: 4,541 Restricted Stock Unit → 4,541 Class A Common Stock ·
Chan Thomas (TC)Chief Accounting OfficerPayment of exercise price or tax liability (F)Table I · Disposed · Class A Common Stock5,149$3.73$19,206See lot detailAug 15, 2026
4 filed lots
  • Table I · Class A Common Stock: 638 shares at $3.73 · code F · owned after 9,194 ·
  • Table I · Class A Common Stock: 858 shares at $3.73 · code F · owned after 10,022 ·
  • Table I · Class A Common Stock: 1,342 shares at $3.73 · code F · owned after 11,316 ·
  • Table I · Class A Common Stock: 2,311 shares at $3.73 · code F · owned after 13,546 ·
Chan Thomas (TC)Chief Accounting OfficerExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 4 paired events10,115Exercise or conversion of derivative security (M)See lot detailAug 15, 2026
4 filed lots
  • Table II · Restricted Stock Unit: 2,636 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 26,367 · Paired event: 2,636 Restricted Stock Unit → 2,636 Class A Common Stock ·
  • Table II · Restricted Stock Unit: 4,541 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 49,953 · Paired event: 4,541 Restricted Stock Unit → 4,541 Class A Common Stock ·
  • Table II · Restricted Stock Unit: 1,252 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 0 · Paired event: 1,252 Restricted Stock Unit → 1,252 Class A Common Stock ·
  • Table II · Restricted Stock Unit: 1,686 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 5,059 · Paired event: 1,686 Restricted Stock Unit → 1,686 Class A Common Stock ·
Fengler JustinSee RemarksExercise or conversion of derivative security (M)Table I · Acquired · Class A Common Stock · 4 paired events48,532Not disclosedNot disclosedSee lot detailAug 15, 2026
4 filed lots
  • Table I · Class A Common Stock: 10,149 shares at Not disclosed · code M · owned after 33,800 · Paired event: 10,149 Restricted Stock Unit → 10,149 Class A Common Stock ·
  • Table I · Class A Common Stock: 6,423 shares at Not disclosed · code M · owned after 35,648 · Paired event: 6,423 Restricted Stock Unit → 6,423 Class A Common Stock ·
  • Table I · Class A Common Stock: 6,392 shares at Not disclosed · code M · owned after 39,223 · Paired event: 6,392 Restricted Stock Unit → 6,392 Class A Common Stock ·
  • Table I · Class A Common Stock: 25,568 shares at Not disclosed · code M · owned after 61,988 · Paired event: 25,568 Restricted Stock Unit → 25,568 Class A Common Stock ·
Fengler JustinSee RemarksPayment of exercise price or tax liability (F)Table I · Disposed · Class A Common Stock21,407$3.73$79,848See lot detailAug 15, 2026
4 filed lots
  • Table I · Class A Common Stock: 4,575 shares at $3.73 · code F · owned after 29,225 ·
  • Table I · Class A Common Stock: 2,817 shares at $3.73 · code F · owned after 32,831 ·
  • Table I · Class A Common Stock: 2,803 shares at $3.73 · code F · owned after 36,420 ·
  • Table I · Class A Common Stock: 11,212 shares at $3.73 · code F · owned after 50,776 ·
Fengler JustinSee RemarksExercise or conversion of derivative security (M)Table II · Disposed · Restricted Stock Unit · 4 paired events48,532Exercise or conversion of derivative security (M)See lot detailAug 15, 2026
4 filed lots
  • Table II · Restricted Stock Unit: 6,392 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 63,919 · Paired event: 6,392 Restricted Stock Unit → 6,392 Class A Common Stock ·
  • Table II · Restricted Stock Unit: 25,568 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 51,135 · Paired event: 25,568 Restricted Stock Unit → 25,568 Class A Common Stock ·
  • Table II · Restricted Stock Unit: 10,149 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 0 · Paired event: 10,149 Restricted Stock Unit → 10,149 Class A Common Stock ·
  • Table II · Restricted Stock Unit: 6,423 shares at — (Exercise or conversion of derivative security (M)) · code M · owned after 19,272 · Paired event: 6,423 Restricted Stock Unit → 6,423 Class A Common Stock ·
Fengler JustinSee RemarksGrant, award, or other acquisition (A)Table II · Acquired · Restricted Stock Unit190,204Grant, award, or other acquisition (A)190,204Aug 10, 2026
1 filed lot
  • Table II · Restricted Stock Unit: 190,204 shares at — (Grant, award, or other acquisition (A)) · code A · owned after 190,204 ·

Source-event as of . Retrieved .

Track record

How GoodRx Holdings, Inc.’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.

Point-in-time scores 20202025, one methodology version · reconstructed from filings on file each Dec 31 — never with hindsight

Point-in-time Moat Score (dot colored by tier)Indexed price (total-return (dividends reinvested))Rated Wide-moat that year

How to read this: each dot is what the engine would have scored GDRX on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.

0406080100WideNarrowShallowNo moatPoint-in-time Moat Score102050100Indexed price · log scale (2021 = 100)2020202120222023202420252026

Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The price path is a total-return (dividends reinvested) index built from the same data the forward returns use; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.

What followed, in the years it rated Wide

In the reconstructed history shown, GDRX did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.

Technology context

#383 of 744 scored Technology companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #381WDAY WORKDAY, INC.44.6 out of 100, Shallow moatShallow moat
  2. #382DTST DATA STORAGE CORPORATION44.6 out of 100, Shallow moatShallow moat
  3. #384ZIP ZIPRECRUITER, INC.44.5 out of 100, Shallow moatShallow moat
  4. #385NXTT NEXT TECHNOLOGY HOLDING INC44.5 out of 100, Shallow moatShallow moat

Compare GDRX with its nearest peersAll Technology companies on the Index →

Common questions about GDRX

Does GoodRx Holdings, Inc. have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores GoodRx Holdings, Inc. (GDRX) 44.6 out of 100 — a Shallow moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 63, pricing power not measurable from the filings, returns on capital 0, balance-sheet safety 37, capital allocation 78.
Is GDRX trading below the conservative owner-earnings estimate?
The value if growth stopped today — a zero-growth baseline — is $2.64 per share. It capitalizes normalized owner earnings at a 9% rate and assumes 0% growth. Versus a recent price of $2.96, that is 12% above value if growth stopped today. The model also publishes a capped-growth comparison, but the zero-growth estimate is the cautious baseline. It assumes trailing owner earnings persist and is unreliable for declining businesses. This is an educational estimate from primary SEC filings, not intrinsic value as a fact or investment advice.
How has GDRX's Moat Score changed over time?
The record logs 16 readings since Jul 17, 2026; the latest reads 44.6 out of 100 (shallow moat). No tier changes on record yet. (Methodology or normalizer upgrades on Jul 20, 2026, Jul 23, 2026, Jul 26, 2026 re-based the score; readings across versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.